ClinConnect ClinConnect Logo
Search / Trial NCT05448560

A Multilevel Intervention to Improve Adherence to Childhood Cancer Survivorship

Launched by GEORGETOWN UNIVERSITY · Jul 4, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Childhood Cancer Survivors Survivorship Care Randomized Controlled Trial

ClinConnect Summary

This clinical trial is studying a new way to help childhood cancer survivors get the follow-up care they need after treatment. Many children who survive cancer face serious health issues later on, but less than 20% of them receive the recommended care from specialized clinics. The trial will test a combination of methods to improve care access and understanding, including online education, personalized information through health record portals, regular phone communication between cancer centers and primary care doctors, and in-person visits. The goal is to help these survivors stay healthy and ensure they receive the proper check-ups for any late effects of their cancer treatment.

To be eligible for this trial, participants must have been diagnosed with cancer before age 21 and have completed treatment (like chemotherapy or radiation) 2 to 4 years ago. They should be cancer-free and able to live for at least two more years. Participants can include children and teens, as well as their parents or guardians if they are under 18 and speak English or Spanish. The trial is currently looking for volunteers at specific hospitals across the country. If you join, you can expect to receive helpful education and support to manage your health as a survivor, making it easier to stay on track with your care.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Diagnosed with any cancer at age \<21 years
  • 2. Treated with chemotherapy and/or radiation
  • 3. 2.0-4.0 years status post-completion of all cancer-related therapy
  • 4. Cancer-free with a life expectancy of ≥2 years
  • 5. English- or Spanish-speaking (also applies to parent/guardian if patient age \<18 years)
  • 6. No previous attendance at a specialty survivorship clinic
  • 7. Followed at one of the 4 participating sites: Hackensack, University of North Carolina- Chapel Hill (UNC), University of Colorado Denver (CU), Miller's Children's and Women's Hospital Long Beach (MCWH)
  • Exclusion Criteria:
  • Active medical problems severe enough to not be eligible for receiving survivorship care with primary care provider at the time of recruitment

About Georgetown University

Georgetown University is a prestigious academic institution renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, Georgetown University leverages its extensive resources and expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among multidisciplinary teams, emphasizing ethical practices and adherence to regulatory standards. With a focus on translating scientific discoveries into clinical applications, Georgetown University plays a vital role in enhancing patient care and contributing to the broader medical community.

Locations

Hackensack, New Jersey, United States

Denver, Colorado, United States

Long Beach, California, United States

Chapel Hill, North Carolina, United States

Patients applied

0 patients applied

Trial Officials

Nina Kadan-Lottick, MD, MSPH

Principal Investigator

Georgetown Lombardi Comprehensive Cancer Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials